Using the clinical data of this large patient collective and a broad number of intestinal tissue and serum samples, we identified the relevance of the IBD-associated TPL2 variation for the disease course of IBD patients on a clinical and molecular level. The gene discussed is MAP3K8; the disease is inflammatory bowel disease.